| Literature DB >> 31019335 |
Isa Félix Adôrno1, Tiago Kojun Tibana1, Rômulo Florêncio Tristão Santos1, Victor Machado Mendes Leão1, Yvone Maia Brustoloni1, Pedro Augusto Ignácio Silva1, Marco Antônio Ferreira1, Thiago Franchi Nunes1.
Abstract
OBJECTIVE: To evaluate chest X-ray findings in pediatric patients diagnosed with influenza A (H1N1) virus infection.Entities:
Keywords: Influenza A virus, H1N1 subtype; Influenza, human; Radiography, thoracic
Year: 2019 PMID: 31019335 PMCID: PMC6472857 DOI: 10.1590/0100-3984.2018.0030
Source DB: PubMed Journal: Radiol Bras ISSN: 0100-3984
Demographic and clinical characteristics of pediatric patients with H1N1 infection.
| Characteristic | Value (n = 17) |
|---|---|
| Female, n (%) | 8 (47.1) |
| Age (months), median (interquartile range) | 9 (52.9) |
| Not requiring ventilatory support, n (%) | 10 (58.8) |
| Requiring ventilatory support, n (%) | 14 (2-89) |
| Vaccination, n (%) | |
| Yes | 2 (11.8) |
| No | 4 (23.5) |
| No data | 11 (64.7) |
| Death, n (%) | 2 (11.8) |
| Oxygen saturation (%), mean ± SD | 93.5 ± 9.9 |
| Respiratory rate (breaths/min), mean ± SD | 50.9 ± 18.1 |
| Fever, n (%) | 17 (100.0) |
| Cough, n (%) | 17 (100.0) |
| Coryza, n (%) | 7 (41.2) |
| Vomiting, n (%) | 6 (35.3) |
| Diarrhea, n (%) | 2 (12.5) |
| Sore throat, n (%) | 2 (11.8) |
| Duration of signs and symptoms (days), median | 4 (1-15) |
| (interquartile range) |
One patient was not assessed. SD, standard deviation.
Radiographic findings in pediatric patients with H1N1 infection.
| Radiographic finding | Value (n = 17) |
|---|---|
| Abnormalities on initial X-ray, n (%) | |
| Peribronchovascular opacities | 5 (29.4) |
| Nonspecific alveolar opacity | 2 (11.8) |
| Peribronchovascular opacities + ground-glass pattern | 4 (23.5) |
| Consolidation | 3 (17.6) |
| Peribronchovascular opacities + consolidation | 1 (5.9) |
| Consolidation + nonspecific alveolar opacity | 1 (5.9) |
| Peribronchovascular opacities + nonspecific alveolar | 1 (5.9) |
| opacity + consolidation | |
| Consolidation in isolation or accompanied by other | 6 (35.3) |
| patterns, n (%) | |
| Extent, n (%) | |
| < 25% | 9 (52.9) |
| > 25% | 8 (47.1) |
| Laterality, n (%) | |
| Bilateral | 11 (64.7) |
| Unilateral | 6 (35.3) |
| Symmetry, n (%) | |
| Symmetric | 4 (23.5) |
| Asymmetric | 13 (76.5) |
| Zone involved, n (%) | |
| Upper | 1 (5.9) |
| Middle | 5 (29.4) |
| Lower | 2 (11.8) |
| All | 9 (52.9) |
| Distribution, n (%) | |
| Central and peripheral | 10 (58.8) |
| Central | 6 (35.3) |
| Peripheral | 1 (5.9) |
| Pleural effusion, n (%) | |
| Unilateral | 4 (23.5) |
| Absent | 13 (76.5) |
Figure 1A 2-month-old female patient who presented with a 72-h history of productive cough and nasal obstruction, evolving to fever, dyspnea, and respiratory distress, therefore requiring oxygen therapy and continuous monitoring. An initial X-ray showing asymmetric peribronchovascular opacities in the middle third of the right lung, with central distribution and affecting less than 25% of the lung.
Figure 2An 11-month-old female patient who presented with a 5-day history of fever, productive cough, and vomiting. An X-ray showing asymmetric unilateral alveolar consolidation in the upper third of the right lung, with central and peripheral distribution and an extent of less than 25%, together with a retrocardiac opacity on the left.
Figure 3A 13-month-old female patient who presented with productive cough and coryza, evolving to loss of appetite, adynamia, and a decline in general health status. She evolved to drowsiness, intense dyspnea, and high fever, requiring ventilatory support. An X-ray showing asymmetric bilateral nonspecific alveolar opacities involving the entire lung, with central and peripheral distribution, affecting more than 25% of the lung.
Radiographic findings in pediatric patients with H1N1 infection, according to the need for ventilatory support.
| Radiographic finding | Ventilatory support required (n = 8) | Ventilatory support not required (n = 9) | P |
|---|---|---|---|
| Abnormalities on initial X-ray, n (%) | 0.073 | ||
| Peribronchovascular opacities | 5 (62.5) | - | |
| Nonspecific alveolar opacity | 1 (12.5) | 1 (11.1) | |
| Peribronchovascular opacities + ground-glass pattern | 1 (12.5) | 3 (33.3) | |
| Consolidation | 1 (12.5) | 2 (22.2) | |
| Peribronchovascular opacities + consolidation | - | 1 (11.1) | |
| Consolidation + nonspecific alveolar opacity | - | 1 (11.1) | |
| Peribronchovascular opacities + nonspecific alveolar opacity + consolidation | - | 1 (11.1) | |
| Consolidation in isolation or accompanied by other patterns, n (%) | 1 (12.5) | 5 (55.6) | 0.131 |
| Extent, n (%) | 0.153 | ||
| < 25% | 6 (75.0) | 3 (33.3) | |
| > 25% | 2 (25.0) | 6 (66.7) | |
| Laterality, n (%) | 0.999 | ||
| Bilateral | 5 (62.5) | 6 (66.7) | |
| Unilateral | 3 (37.5) | 3 (33.3) | |
| Symmetry, n (%) | 0.029 | ||
| Symmetric | 4 (50.0) | - | |
| Asymmetric | 4 (50.0) | 9 (100.0) | |
| Zone involved, n (%) | 0.361 | ||
| Upper | - | 1 (11.1) | |
| Middle | 4 (50.0) | 1 (11.1) | |
| Lower | 1 (12.5) | 1 (11.1) | |
| All | 3 (37.5) | 6 (66.7) | |
| Distribution, n (%) | 0.079 | ||
| Central and peripheral | 3 (37.5) | 7 (77.8) | |
| Central | 5 (62.5) | 1 (11.1) | |
| Peripheral | - | 1 (11.1) |
Clinical characteristics of pediatric patients with H1N1 infection, according to the need for ventilatory support.
| Ventilatory support required (n = 8) | Ventilatory support not required (n = 9) | ||
|---|---|---|---|
| Characteristic | |||
| Female, n (%) | 5 (62.5) | 5 (55.6) | 0.999 |
| Age (months), median (interquartile range) | 18 (2-72) | 14 (9-89) | 0.481 |
| Vaccination, n (%) | 0.999 | ||
| Yes | 1 (12.5) | 1 (11.1) | |
| No | 2 (25.0) | 2 (22.2) | |
| No data | 5 (62.5) | 6 (66.7) | |
| Death, n (%) | - | 2 (22.2) | 0.471 |
| Oxygen saturation (%), mean ± SD | 93.4 ± 4.3 | 93.6 ± 13.4 | 0.971 |
| Respiratory rate (breaths/min), mean ± SD | 53.1 ± 24.6 | 48.6 ± 9.2 | 0.640 |
| Fever, n (%) | 8 (100.0) | 9 (100.0) | 1.000 |
| Cough, n (%) | 8 (100.0) | 9 (100.0) | 1.000 |
| Coryza, n (%) | 3 (37.5) | 4 (44.4) | 0.999 |
| Vomiting, n (%) | 1 (12.5) | 5 (55.6) | 0.131 |
| Diarrhea, n (%)† | 1 (14.3) | 1 (11.1) | 0.999 |
| Sore throat, n (%) | - | 2 (22.2) | 0.471 |
| Duration of signs and symptoms (days), median (interquartile range) | 4 (1-7) | 4 (1-15) | 0.481 |
* One patient was not assessed. SD, standard deviation.